The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, Zhou J, Wang L, Zhao L, Liu YB, Yuan WT, Yang L, Shen ZZ, Huang W, Shao ZM.
Li WF, et al. Among authors: zhou j.
Breast Cancer Res Treat. 2008 Jul;110(1):99-109. doi: 10.1007/s10549-007-9708-3. Epub 2007 Sep 13.
Breast Cancer Res Treat. 2008.
PMID: 17851763